• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
3-Bromo-4-fluorobenzaldehyde
5-Methyl-1,3,4-oxadiazol2(3H)-one
4-Amino-6-methyl-3 oxo2,3, 4,5-tetrahydro 1.2.4-triazine hydrochloride
4-Acetylamino-6-methyl -3-oxo-2,3,4,5-tetrahydro-1,2,4-triazine
3-Pyridinecarboxaldehyde
Ethyl 3 Fluorobenzoate

Divi’s, Gland, Fidelity enter race to buy Orchid Pharma

firstwordpharmaMarch 04, 2019

Tag: Divi’s , Fidelity , Orchid Pharma , Gland

  • The Economic Times reported that Divi's Laboratories, Divi’s Laboratories Gland Celsus Bio Chemicals and Fidelity Trading Corporation have shown preliminary interest in taking over Orchid Pharma.

  • Other bidders keen to acquire the bulk cephalosporin drugmaker include financial investors Everstone, Piramal Capital, AION Capital, ART Capital and Finquest Group.

  • The news comes after the Chennai bench of the National Company Law Tribunal (NCLT) knocked back a proposal by Ingen Capital to take over Orchid Pharma after it failed to bring in the requisite money.

Register as Visitor to CPhI China 2019!

Previous:Pharma Can BMS rebels scuttle its Celgene buy? Analysts do the math—and so far, the votes don't add up

Next:Eli Lilly to launch authorised Humalog generic in the US at 50-percent lower list price

Related News

Sartorius Stedim Biotech Opens New Center for Bioprocess Innovation in Marlborough, USA

PharmaSourcesNovember 22, 2024

Sartorius Stedim Biotech, a leading partner of the biopharmaceutical industry, today opened its new Center for Bioprocess Innovation in Marlborough, Massachusetts.

BioPharmaSpec Announces Three New Facilities in Freiburg, Bergamo and Vilnius

Biotech NewswireNovember 20, 2024

Rona Therapeutics Presented Positive Phase 1 Results of RN0191, a Novel siRNA Therapy Targeting PCSK9, at the 2024 American Heart Association (AHA) Scientific Sessions

PR NEWSWIRENovember 20, 2024

Divi’s, Gland, Fidelity enter race to buy Orchid Pharma | Pharmasources.com

AI in Pharmacovigilance: Predicting & Preventing Drug Risks

Nurah EkhlaqueNovember 19, 2024

Discover how AI in pharmacovigilance improves drug safety by predicting risks, identifying harmful interactions, and enhancing patient outcomes.

You may like
More>>

Prostaglandin intermediate104121-92-8

Prostaglandin intermediate104121-92-8
Prostaglandin intermediate41639-72-9

Prostaglandin intermediate41639-72-9
Prostaglandin intermediate64072-25-9

Prostaglandin intermediate64072-25-9
Prostaglandin intermediate40834-88-6

Prostaglandin intermediate40834-88-6
Prostaglandin intermediate69552-46-1

Prostaglandin intermediate69552-46-1
Prostaglandin intermediate51014-26-7

Prostaglandin intermediate51014-26-7
Prostaglandin intermediate26115-01-5

Prostaglandin intermediate26115-01-5
Prostaglandin intermediate81846-28-8

Prostaglandin intermediate81846-28-8
Prostaglandin intermediate54276-17-4

Prostaglandin intermediate54276-17-4
Prostaglandin intermediate81846-27-7

Prostaglandin intermediate81846-27-7

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service